Lupin Limited has acquired the specialty product portfolio of Temmler Pharma GmbH & Co. KG. Based in Marburg, Germany, Temmler, which is a part of the Aenova Group, one of the world’s largest pharmaceutical contract manufacturers, has a growing specialty portfolio of 13 products including key central nervous system (CNS) products and specialty products that address rare disease areas like Myasthenia Gravis, Huntington disease as well as fast-growing dermatology products for anti-wart treatme...